Ms Anne O’Driscoll and Dr Martin Fahy to Join the Board of FINEOS
7.5.2019 13:35:00 EEST | Business Wire | Press release
FINEOS Corporation, the market-leading provider of group, voluntary and individual core systems for life, accident and health insurance, today announced that Ms Anne O’Driscoll and Dr Martin Fahy have joined the FINEOS Board as Non-Executive Directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190507005496/en/
l-r Anne O'Driscoll, Martin Fahy, Michael Kelly, Peter Le Beau, Gilles Biscay, Tom Wall (Photo: Business Wire)
Anne is a chartered accountant and is on the boards of Comminsure insurance, Steadfast Group Limited and Infomedia Limited, as well as MDA National Pty Limited. Anne began her career with PwC in London. She moved to Sydney, Australia, with PwC and then in 1992 she joined IAG insurance, one of Australia’s largest insurers. Following 13 years with IAG Anne moved to Genworth Australia, as CFO. She is well known within the Australian insurance market and has an exemplary track record as a company director.
Martin is currently the CEO of the Association of Superannuation Funds of Australia (ASFA). He was previously a partner at KPMG, where he worked with clients across financial services and other sectors to drive transformational change. From 2007 to 2011, Martin was CEO at the Financial Services Institute of Australasia (FINSIA). Prior to FINSIA, he led strategy and development for the Chartered Institute of Management Accountants (CIMA) in Asia Pacific. Martin holds a PhD from the National University of Ireland, is a former senior Fulbright scholar and has extensive research and policy experience from his time as an academic. He is also an Adjunct Professor at the University of Technology Sydney, where he is also Chair of the Centre for Management and Organisational Studies (CMOS) Advisory Board.
Dr Fahy will be the keynote presenter at the FINEOS APAC Summit, which will be taking place in Sydney on May 23. We are looking forward to his presentation entitled “The Changing Insurance Landscape: Delivering Flawless Execution and Transformation in an Increasingly Regulated World.”
“We are delighted that Anne and Martin have agreed to serve as FINEOS directors and look forward to benefitting from their judgment and insight. Their experience across financial services and IT transformation will add a valuable perspective to our Board” said Peter le Beau, Chairman of the FINEOS Board.
About FINEOS Corporation
FINEOS has over 50 life, accident and health insurance customers globally; including 7 of the top ten carriers in the US and 4 of the top 5 carriers in Australia. With employees and offices throughout the world, FINEOS continues to scale rapidly, working with innovative progressive carriers in North America, Europe, and Asia Pacific.
The FINEOS Platform provides full end to end core claims, billing and policy administration for group, voluntary and individual business across life, accident and health. The FINEOS Platform includes the FINEOS AdminSuite core product suite as well as add-on products, FINEOS Engage to support digital engagement and FINEOS Insight for analytics and reporting.
For more information, visit www.FINEOS.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190507005496/en/
Contact information
Victoria Jamison
Marketing Manager
FINEOS Corporation
+
353 1 639 9700
victoria.jamison@FINEOS.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HyperLight Demonstrates Low-Power 1.6T-DR8 TFLN-based Reference Transceiver Assembled by TFC16.3.2026 14:03:00 EET | Press release
HyperLight Corporation (“HyperLight”) today announced a major milestone in low-power optical networking with the demonstration of a 1.6T-DR8 optical transceiver leveraging HyperLight’s TFLN Chiplet™ Platform. The reference module was demonstrated with engineering and manufacturing support from Suzhou TFC Optical Communication Co., Ltd. (SZSE: 300394, or "TFC"). The reference design achieves 20W power consumption in a fully retimed 1.6T-DR8 module, representing approximately 20% lower module-level power compared to alternative technologies. The reduction is achieved through a simple drop-in transmitter implementation based on a single thin-film lithium niobate photonic integrated circuit (TFLN PIC). The TFLN transmitter enables the module to operate using a single continuous-wave (CW) laser, compared to the two to four lasers typically required in conventional implementations. Additional energy savings are achieved through the ability to operate directly from the native low-swing electr
GCE® Launches Gascontrol.com Website Showcasing Its Complete Gas Control Portfolio for Speciality, Medical, and Industrial Applications16.3.2026 14:00:00 EET | Press release
GCE®, a global market leader for gas control equipment, has launched gascontrol.com, a new website designed to better serve customers across its GCE Specialty, GCE Medical, and GCE Industrial product portfolios. The new site provides a streamlined, market-focused experience that makes it easier for users to explore GCE’s gas control solutions and identify the right products. A new Documentation Search Tool assists customers in easily finding documents such as instructions for use (IFUs), appendices, and certifications through an intuitive search interface. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316410525/en/ GCE’s new website, gascontrol.com, provides a streamlined, market-focused experience across the GCE Specialty, GCE Medical, and GCE Industrial product portfolios. “The redesigned website reflects GCE’s role as a comprehensive, trusted supplier of gas control technologies that elevate industries and improve liv
SBC Medical Announces Opening of Brand Flagship "NEO Skin Clinic Ginza."16.3.2026 14:00:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that its specialized aesthetic brand, “NEO Skin Clinic,” will open its flagship location in Tokyo’s Ginza district, a globally recognized medical tourism hub and highly competitive district, on Saturday, March 28, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312457783/en/ SBC Medical Announces Opening of Brand Flagship "NEO Skin Clinic Ginza." The Ginza flagship, located in a prime area near GINZA SIX, will feature dedicated VIP rooms for executive clientele and the growing number of international patients, strengthening the brand’s global presence. Leveraging its robust network of 283 affiliated clinics (as of December 2025) and extensive clinical data, SBC Medical continues to advance its multi-bran
Lebrikizumab Delivered Significant Skin Clearance and Improved Disease Severity in Children With Moderate-to-severe Atopic Dermatitis16.3.2026 12:53:00 EET | Press release
Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced positive, top-line results from the pivotal Phase 3 ADorable-1 trial evaluating efficacy and safety of lebrikizumab for children and adolescents with moderate-to-severe atopic dermatitis aged 6 months to <18 years. Lebrikizumab met both co-primary and key secondary endpoints, delivering near-complete skin clearance, reduced disease severity, itch relief and improved quality of life at Week 16. Skin conditions can have a significant impact on people’s lives, both physically and emotionally3. Atopic dermatitis is more prevalent in childhood than adulthood and typically begins early in life4, with most cases appearing by the first year of life (60%) or before 5 years of age (85%)5. The emotional impact of atopic dermatitis can disrupt crucial formative years, with disease burden increasing alongside severity and often leading to sleep disruption, school absenteeism, and difficulties in
Experian Marks a Breakthrough in Consumer AI with the Next Evolution of Its Virtual Assistant16.3.2026 12:00:00 EET | Press release
Experian today unveiled the next evolution of the Experian Virtual Assistant, EVA™, a significant advancement in its Consumer First AI strategy that expands personalized, conversational financial guidance to millions of consumers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316538160/en/ Experian today unveiled the next evolution of the Experian Virtual Assistant, EVA™. “This next generation of EVA reflects the direction of our consumer AI strategy,” said Debbie Hsu, Executive Vice President of Product, Experian Consumer Services. “We are bringing together conversational AI, personalization, and our trusted data foundation to deliver guidance that is intuitive, relevant, and actionable. Our focus is on helping consumers make smarter financial decisions in ways that feel simple and empowering.” Built to scale intelligent financial guidance through a more adaptive experience, the enhanced EVA expands beyond credit insigh
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom